Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
$72.5 - $100.68 $374,027 - $519,408
-5,159 Closed
0 $0
Q3 2021

Oct 08, 2021

SELL
$90.24 - $124.05 $45,029 - $61,900
-499 Reduced 8.82%
5,159 $492,000
Q2 2021

Jul 14, 2021

BUY
$93.66 - $139.27 $6,181 - $9,191
66 Added 1.18%
5,658 $703,000
Q1 2021

Apr 13, 2021

SELL
$116.57 - $155.01 $196,537 - $261,346
-1,686 Reduced 23.17%
5,592 $737,000
Q4 2020

Jan 25, 2021

BUY
$99.61 - $142.12 $724,961 - $1.03 Million
7,278 New
7,278 $964,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Golden Green, Inc. Portfolio

Follow Golden Green, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Golden Green, Inc. with notifications on news.